Skip to main content
. Author manuscript; available in PMC: 2015 May 8.
Published in final edited form as: Expert Rev Vaccines. 2009 Sep;8(9):1251–1276. doi: 10.1586/erv.09.77

Table 5.

Feline leukemia virus vaccines.

Vaccine Vector Dosage Price Vaccination
ages
Immune
response
Protection Ref.
Leucogen
(Virbac,
France)
p45 envelope antigen
with adjuvant
(aluminium hydroxide
gel, extract of Quillaja
saponaria)
Two initial doses at
3–4-week intervals
injected im., annual
revaccination
with single dose
US$99.99/ten
doses
(US$9.99/dose)
8 weeks Neutralizing
antibodies
within 9 weeks
80% preventable
fraction against
persistent viremia
[88]
Purevax®/
Eurifel
(Merial
Animal
Health Ltd,
UK)
Canarypox virus with
env and gag genes and
part of the pol gene of
subgroup A (no
adjuvant)
Two initial doses of
0.25 ml 3–4 weeks
apart sc., annual
revaccination with
single dose
US$121.99/25
doses
(US$4.88/
dose)
8 weeks Cytotoxic T-cell
response, very
limited
neutralizing
antibody
production
78% preventable
fraction for
persistent viremia
[89]
Leukocell 2
(Pfizer, NY,
USA)
Inactivated,
adjuvanted, mixed
subunits from
FeLV strains A, B and
C, with sterile adjuvant
Two initial doses of
1 ml 3–4 weeks
apart sc., annual
revaccination with
single dose
US$50.70/ten
doses
(US$5.07/dose)
9 weeks Neutralizing
antibodies
within 7 weeks
Protects more
than 70% of
artificially
immunosuppressed
cats against
persistent viremia
[90]
Fel-O-Vax
LvK (Fort
Dodge, KS,
USA)
Inactivated whole virus
of subgroups A and B
with adjuvant
Two initial doses of
1 ml 3–4 weeks
apart sc. or
im., annual
revaccination with
single dose
US$74.00/ten
doses
(US$7.40/dose)
9 weeks Neutralizing
antibodies
within
11 weeks
44–100%
preventable
fraction
Fevaxyn
(Schering-
Plough, NJ,
USA)
Inactivated whole virus
of subgroups A and B
with adjuvant
Two initial doses of
1 ml 3–4 weeks
apart sc., annual
revaccination with
single dose
US$119.99/25
doses
(US$4.80/
dose)
9 weeks Unknown 90.4–100%
preventable
fraction
DNA vaccine
(Hanlon
et al. 2001)
Two plasmids
expressing gag/pol and
env gene with adjuvant
plasmids encoding
feline IL-12, IL-18
and/or IFN-γ
100 µg of each
DNA construct
injected im.
Unknown 13–15 weeks Unknown 100% protection
against transient
and persistent
viremia, 5/6 kittens
protected against
latent infection
[18]

FeLV: Feline leukemia virus; im.: Intramuscular; sc.: Subcutaneous.